These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 3105869)

  • 1. Estrogen receptor binding to nuclei from normal and neoplastic rat mammary tissues in vitro.
    Klinge CM; Bambara RA; Zain S; Hilf R
    Cancer Res; 1987 Jun; 47(11):2852-9. PubMed ID: 3105869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of host hormonal status on binding of activated estrogen receptor to nuclei from R3230AC and 7,12-dimethylbenz[a]anthracene-induced mammary tumors.
    Klinge CM; Bambara RA; Zain S; Hilf R
    Cancer Res; 1989 Mar; 49(5):1165-70. PubMed ID: 2492902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclease sensitivity of estradiol-charged estrogen receptor binding sites in nuclei isolated from normal and neoplastic rat mammary tissues.
    Klinge CM; Bambara RA; Zain S; Hilf R
    J Steroid Biochem; 1990 Jun; 36(1-2):7-14. PubMed ID: 2194077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin binding to mammary gland, 7,12-dimethylbenz(a)-anthracene-induced mammary tumors, and liver in rats.
    Smith RD; Hilf R; Senior AE
    Cancer Res; 1976 Oct; 36(10):3726-31. PubMed ID: 821605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGF receptors in R3230AC rat mammary carcinomas: characteristics and regulation in vitro and in vivo.
    Ryan PD; Hilf R
    Oncol Res; 1992; 4(4-5):181-92. PubMed ID: 1504378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid-binding proteins of the mammary gland and their clinical significance in breast cancer.
    Wittliff JL; Mehta RG; Boyd PA; Goral JE
    J Toxicol Environ Health Suppl; 1976; 1():231-56. PubMed ID: 186628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin regulation of estrogen and progesterone receptors in normal and neoplastic mouse mammary tissue.
    Koseki Y; Cole D; Matsuzawa A; Costlow ME
    Jpn J Cancer Res; 1987 Oct; 78(10):1105-11. PubMed ID: 3119544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin binding to dissociated cells from rat mammary tumors and mammary gland.
    Smith RD; Hilf R; Senior AE
    Cancer Biochem Biophys; 1979; 3(3):117-21. PubMed ID: 121922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism of development and growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by the antiestrogen U 23,469 and effects on estrogen and progesterone receptors.
    Tsai TL; Katzenellenbogen BS
    Cancer Res; 1977 May; 37(5):1537-43. PubMed ID: 404032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of prenatal exposure to diethylstilbestrol on estrogen and progestin binding proteins in uteri and dimethylbenzanthracene- induced mammary tumors of the rat.
    Heidemann PH; Wittliff JL; Calhoon RE; Boylan ES
    J Toxicol Environ Health; 1981 Oct; 8(4):667-86. PubMed ID: 6802985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of estrogen-binding capacity by insulin in 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
    Gibson SL; Hilf R
    Cancer Res; 1980 Jul; 40(7):2343-8. PubMed ID: 6770998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiestrogen(4-hydroxytamoxifen)-charged estrogen receptor binding to nuclei from normal and neoplastic rat mammary tissues is not affected by host hormonal status.
    Klinge CM; Knox DT; Bambara RA; Zain S; Hilf R
    J Steroid Biochem; 1989 Sep; 33(3):335-40. PubMed ID: 2779224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of progesterone-binding components in neoplastic mammary tissues of the rat.
    Goral JE; Wittliff JL
    Cancer Res; 1976 Jun; 36(6):1886-93. PubMed ID: 178435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin binding to R3230AC mammary carcinoma and liver in hormone-treated and diabetic rats.
    Smith RD; Hilf R; Senior AE
    Cancer Res; 1977 Feb; 37(2):595-8. PubMed ID: 188551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An endogenous inhibitor of [3H]estradiol binding to nuclear type II estrogen binding sites in normal and malignant tissues.
    Markaverich BM; Roberts RR; Alejandro MA; Clark JH
    Cancer Res; 1984 Apr; 44(4):1515-9. PubMed ID: 6704964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid hormone receptor expression and proliferation in rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
    Qiu C; Shan L; Yu M; Snyderwine EG
    Carcinogenesis; 2005 Apr; 26(4):763-9. PubMed ID: 15637090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a unique nuclear estrogen-binding component in an estrogen-responsive mouse Leydig cell tumor.
    Maeda Y; Sato B; Noma K; Kishimoto S; Koizumi K; Aono T; Matsumoto K
    Cancer Res; 1983 Sep; 43(9):4091-7. PubMed ID: 6871850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similarities and differences in the ultrastructure of two hormone-dependent and one independent human breast carcinoma grown in athymic nude mice: comparison with the rat DMBA-induced tumor and normal secretory mammocytes.
    Anderson WA; Perotti ME; McManaway M; Lindsey S; Eckberg WR
    J Submicrosc Cytol; 1984 Oct; 16(4):673-90. PubMed ID: 6438351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of the interaction between different forms of estrogen receptors and cell nuclei].
    Mataradze GD; Gontar' EV; Kondrat'ev IaIu; Rozen VB
    Biokhimiia; 1982 May; 47(5):869-78. PubMed ID: 7093387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor characteristics of the rat mammary carcinoma cell line 64-24.
    Eil C; Douglass EC; Rosenburg SM; Kano-Sueoka T
    Cancer Res; 1981 Jan; 41(1):42-8. PubMed ID: 6256064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.